Literature DB >> 25299419

Expedited partner therapy for sexually transmitted diseases--are we there yet?

Patricia J Kissinger1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25299419      PMCID： PMC4221741          DOI： 10.1097/OLQ.0000000000000207

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN： 0148-5717            Impact factor:   2.830


× No keyword cloud information.
  15 in total

Review 1.  The estimated direct medical cost of sexually transmitted diseases among American youth, 2000.

Authors:  Harrell W Chesson; John M Blandford; Thomas L Gift; Guoyu Tao; Kathleen L Irwin
Journal:  Perspect Sex Reprod Health       Date:  2004 Jan-Feb

2.  Adolescents' attitudes toward expedited partner therapy for sexually transmitted infections.

Authors:  Ana Radovic; Gale R Burstein; Michael P Marshal; Pamela J Murray; Elizabeth Miller; Gina S Sucato
Journal:  Sex Transm Dis       Date:  2013-11       Impact factor: 2.830

3.  Patient-delivered partner treatment for male urethritis: a randomized, controlled trial.

Authors:  Patricia Kissinger; Hamish Mohammed; Gwangi Richardson-Alston; Jami S Leichliter; Stephanie N Taylor; David H Martin; Thomas A Farley
Journal:  Clin Infect Dis       Date:  2005-07-19       Impact factor: 9.079

4.  Patient-delivered partner therapy for sexually transmitted diseases as practiced by U.S. physicians.

Authors:  Matthew Hogben; Donna H McCree; Matthew R Golden
Journal:  Sex Transm Dis       Date:  2005-02       Impact factor: 2.830

5.  Implementation and effectiveness of an expedited partner therapy program in an urban clinic.

Authors:  Theresa Mickiewicz; Alia Al-Tayyib; Mark Thrun; Cornelis Rietmeijer
Journal:  Sex Transm Dis       Date:  2012-12       Impact factor: 2.830

6.  The legal aspects of expedited partner therapy practice: do state laws and policies really matter?

Authors:  Ryan Cramer; Jami S Leichliter; Mark R Stenger; Penny S Loosier; Lauren Slive
Journal:  Sex Transm Dis       Date:  2013-08       Impact factor: 2.830

7.  Partner notification of sexually transmitted diseases: practices and preferences.

Authors:  Priya R Gursahaney; Kwonho Jeong; Bruce W Dixon; Harold C Wiesenfeld
Journal:  Sex Transm Dis       Date:  2011-09       Impact factor: 2.830

8.  Productivity losses attributable to untreated chlamydial infection and associated pelvic inflammatory disease in reproductive-aged women.

Authors:  John M Blandford; Thomas L Gift
Journal:  Sex Transm Dis       Date:  2006-10       Impact factor: 2.830

9.  The cost and cost-effectiveness of expedited partner therapy compared with standard partner referral for the treatment of chlamydia or gonorrhea.

Authors:  Thomas L Gift; Patricia Kissinger; Hamish Mohammed; Jami S Leichliter; Matthew Hogben; Matthew R Golden
Journal:  Sex Transm Dis       Date:  2011-11       Impact factor: 2.830

10.  Early repeat Chlamydia trachomatis and Neisseria gonorrhoeae infections among heterosexual men.

Authors:  Patricia J Kissinger; Kathleen Reilly; Stephanie N Taylor; Jami S Leichliter; Susan Rosenthal; David H Martin
Journal:  Sex Transm Dis       Date:  2009-08       Impact factor: 2.830
View more
  3 in total

1.  Epidemiological Impact of Expedited Partner Therapy for Men Who Have Sex With Men: A Modeling Study.

Authors:  Kevin M Weiss; Jeb S Jones; David A Katz; Thomas L Gift; Kyle Bernstein; Kimberly Workowski; Eli S Rosenberg; Samuel M Jenness
Journal:  Sex Transm Dis       Date:  2019-11       Impact factor: 2.830

2.  Public health detailing to increase expedited partner therapy for chlamydia and gonorrhea in Maryland: Changes in awareness and implementation among prescribing community providers.

Authors:  Rachel Milkovich; Christina Schumacher; Xueting Tao; Tina Lamidi; Ashley Edwards; Elisabeth Liebow; Kenneth Ruby; Arik V Marcell; Jacky M Jennings
Journal:  Prev Med Rep       Date:  2021-08-26

3.  A Risk-based Model for Predicting the Impact of using Condoms on the Spread of Sexually Transmitted Infections.

Authors:  Asma Azizi; Karen Ríos-Soto; Anuj Mubayi; James M Hyman
Journal:  Infect Dis Model       Date:  2017-03-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.